COVID & Mental Health

When COVID-19 struck in 2020, mental health impacts were unknown but urgent. Our COVID and Mental Health project brought together Canadian and UK expertise through partnerships with the Canadian Mental Health Association and Mental Health Foundation UK, delivering timely evidence that shaped pandemic mental health responses across multiple sectors.

Related Publications

  • Associations between periods of COVID-19 quarantine and mental health in Canada

    Since the onset of the COVID-19 pandemic, many jurisdictions, including Canada, have made use of public health measures such as COVID-19 quarantine to reduce the transmission of the virus. To examine associations between these periods of quarantine and mental health, including suicidal ideation and deliberate self-harm, we examined data from a national survey of 3000 Canadian adults distributed between May 14-29, 2020.

    Psychiatry Research

    2021/01

    Methods:
  • A portrait of the early and differential mental health impacts of the COVID-19 pandemic in Canada: Findings from the first wave of a nationally representative cross-sectional survey

    Evidence on the population-level mental health impacts of COVID-19 are beginning to amass; however, to date, there are significant gaps in our understandings of whose mental health is most impacted, how the pandemic is contributing to widening mental health inequities, and the coping strategies being used to sustain mental health. This monitoring study highlights the differential mental health impacts of the pandemic for those who experience health, social, and structural inequities.

    Preventative Medicine

    2021/01

    Methods:
  • Use of asynchronous virtual mental health resources for COVID-19 related stress among the general population in Canada: Findings from a nationally representative cross-sectional survey

    The aim of this paper is to examine the use of asynchronous virtual mental health resources in Canada during the COVID-19 pandemic among the general population and among a participant subgroup classified as experiencing an adverse mental health impact related to the pandemic.  

    International Journal of Drug Policy

    2020/12

    Methods: